Transplant Infectious Diseases Program, University of Nebraska Medical Center, Omaha, Nebraska.
Transplant Surgery Program, University of Nebraska Medical Center, Omaha, Nebraska.
Semin Respir Crit Care Med. 2021 Oct;42(5):717-725. doi: 10.1055/s-0041-1735150. Epub 2021 Sep 20.
Sepsis is a complex disease stemming from a dysregulated immune response toward an infectious agent. In transplantation, sepsis remains one of the leading causes of morbidity and mortality. Solid organ transplant recipients have impaired adaptive immunity due to immunosuppression required to prevent rejection. Immunosuppression has unintended consequences, such as increasing the risk of infections and sepsis. Due to its high morbidity and mortality, early detection of sepsis is paramount to start aggressive treatment. Several biomarkers or combination of biomarkers of sepsis have emerged in the last decade, but they are not dependable for early diagnosis or for outcome prognosis.
脓毒症是一种复杂的疾病,源于对感染因子的免疫反应失调。在移植领域,脓毒症仍然是发病率和死亡率的主要原因之一。由于需要免疫抑制来预防排斥反应,实体器官移植受者的适应性免疫受到损害。免疫抑制有一些意外的后果,例如增加感染和脓毒症的风险。由于其高发病率和死亡率,早期发现脓毒症对于开始积极治疗至关重要。过去十年中出现了几种脓毒症的生物标志物或生物标志物组合,但它们不能可靠地用于早期诊断或预后。